Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Type: Journal article
Title: An overview of nanotoxicity and nanomedicine research: principles, progress and implications for cancer therapy
Author: Wang, Y.
Santos, A.
Evdokiou, A.
Losic, D.
Citation: Journal of Materials Chemistry B, 2015; 3(36):7153-7172
Publisher: Royal Society of Chemistry
Issue Date: 2015
ISSN: 2050-750X
Statement of
Ye Wang, Abel Santos, Andreas Evdokiou and Dusan Losic
Abstract: The toxic paradigms of chemotherapeutic drugs and nanoparticles are tightly linked. Whereas uncontrolled exposure of living systems to therapeutics/nanomaterials leads to toxicity, selective induction of cytotoxicity in cancer cells helps in the fight against cancer. The increasing understanding of nanotoxicity paradigms has recently resulted in important benchmarks for the safe design of nanomaterial-based drug delivery systems aiming to fight cancer. In this context, this review aims to compile and present recent advances, outcomes and interconnections between nanomaterial-based drug delivery and nanotoxicity disciplines in order to provide a comprehensive guidance for future research. First, the basic concepts and mechanisms of nanomaterial-based drug delivery and nanotoxicity are introduced. Second, we present a detailed classification of drug delivery strategies and nanotoxicity paradigms, supported by the most recent research studies with a special focus on the interconnections between nanotoxicity and drug delivery research, which are highlighted in order to explore future opportunities for developing advanced therapeutic approaches. Finally, this review is concluded with future prospects on the use of nanoparticles for manipulating the behavior of cells and animals.
Rights: This journal is © The Royal Society of Chemistry 2015
RMID: 0030035565
DOI: 10.1039/c5tb00956a
Appears in Collections:IPAS publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.